Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides.
about
Microemulgel: an overwhelming approach to improve therapeutic action of drug moietyPreclinical lymphatic imaging.Development of silymarin self-microemulsifying drug delivery system with enhanced oral bioavailabilityPreparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin.In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate.Development and Evaluation of Novel Self-Nanoemulsifying Drug Delivery Systems Based on a Homolipid from Capra hircus and Its Admixtures with Melon Oil for the Delivery of IndomethacinCharacterization and evaluation of an oral microemulsion containing the antitumor diterpenoid compound ent-11alpha-hydroxy-15-oxo-kaur-16-en-19-oic-acid.Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.The Increasing Use of Interesterified Lipids in the Food Supply and Their Effects on Health ParametersMechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach.Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).Recent approaches of lipid-based delivery system for lymphatic targeting via oral route.Toxicity evaluation of microemulsion (nano size) of sour cherry kernel extract for the oral bioavailability enhancement.Application of Box-Behnken design in the preparation and optimization of fenofibrate-loaded self-microemulsifying drug delivery system (SMEDDS).Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.Design, characterization and in vitro evaluation of SMEDDS containing an anticancer peptide, linear LyP-1.SNEDDS Containing Poorly Water Soluble Cinnarizine; Development and in Vitro Characterization of Dispersion, Digestion and Solubilization.Characterisation of fenofibrate dissolution delivered by a self-microemulsifying drug-delivery system.New lumefantrine self nanoemulsifying delivery system - will it by-pass lymphatic transport mechanisms?In situ absorption and relative bioavailability studies of zaleplon loaded self-nanoemulsifying powders.Novel delivery systems of atorvastatin should be evaluated for pharmacodynamics instead of pharmacokinetics.Self-microemulsifying drug delivery system and nanoemulsion for enhancing aqueous miscibility of Alpinia galanga oil.In vitro digestion of the self-emulsifying lipid excipient Labrasol(®) by gastrointestinal lipases and influence of its colloidal structure on lipolysis rate.
P2860
Q26743930-7F73B40D-56D2-4ECA-A772-16117E778C8DQ30465292-5D9853FA-65B3-430E-9961-13D1F9928F15Q33986021-E6FB905F-F864-48F6-A7FC-F14CF97A0B85Q34562249-F4F4F7E8-7112-4085-98EA-59066A4F2510Q35488199-1DE5A53C-516C-4050-8919-01E1801E7AEBQ36112240-774B2635-EB7A-4D90-A9EC-FEF4D313072EQ36852023-86C456B4-A166-4EC7-A443-B026AF0229A4Q37066550-03886DF3-B148-4EAA-92B6-7AE6C153E132Q37089767-EED9E508-E5A1-48E0-8074-8C838A8BE3ABQ37336117-596F0F5F-084B-4895-9711-FEFF7130CDB2Q37988960-B2E5DC4C-2C35-400E-87ED-519577EF6C33Q38242314-D0386513-EA44-4E62-855E-0D32D38B949BQ38309953-B4E592B8-82DA-43BC-A8D0-48E458ADEF16Q38448902-3230648F-45D0-4B5A-9CEF-336424631EE5Q38926514-F080A6BA-4E97-408E-8695-C7FB420F8C5FQ39151249-54C76FBD-E3FE-4B41-BC61-41B5D942E564Q41777003-85A5BBE7-7102-45B5-8601-CC31BA5B96D7Q42835474-64E2D987-DE2B-49DC-8716-5F5ED121C1E3Q43099939-BB1989AE-2A9C-48EF-9357-C0B71E51FDBCQ44916197-ABACDBEC-E91C-4B24-AC24-7DAE1D6B50ACQ46919776-5D6FBC87-225E-47A6-A237-E635CDCE0367Q47113494-DF024DD0-842E-4463-BD09-15C7B0FBC331Q51025911-2F5B2242-38E1-4002-A8D8-190B8D7CA1E4
P2860
Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Examination of oral absorption ...... ning structured triglycerides.
@ast
Examination of oral absorption ...... ning structured triglycerides.
@en
Examination of oral absorption ...... lsifying drug delivery systems
@nl
type
label
Examination of oral absorption ...... ning structured triglycerides.
@ast
Examination of oral absorption ...... ning structured triglycerides.
@en
Examination of oral absorption ...... lsifying drug delivery systems
@nl
prefLabel
Examination of oral absorption ...... ning structured triglycerides.
@ast
Examination of oral absorption ...... ning structured triglycerides.
@en
Examination of oral absorption ...... lsifying drug delivery systems
@nl
P2093
P50
P1476
Examination of oral absorption ...... ining structured triglycerides
@en
P2093
Glenn A Edwards
Henning G Kristensen
P356
10.1016/S0928-0987(03)00174-X
P407
P577
2003-09-01T00:00:00Z